Status:
ACTIVE_NOT_RECRUITING
Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Janssen Scientific Affairs, LLC
Conditions:
Arthritis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall objective of this proposal is to test version 3.0 of the Arthritis smartphone app in a 12-month interrupted time series analysis (ITSA) design which will allow us to observe possible diffe...
Detailed Description
Aim 1: To integrate an app for PsA into the EHR. In current work, user-centered design helped develop an EHR integrated PRO-based app for RA. The roll out of the app has been successful and the invest...
Eligibility Criteria
Inclusion
- Be diagnosed with PsA by a board-certified rheumatologist and been seen at least twice in the prior year
- Own a smartphone with either an Android or iPhone operating system
- Be at least 18 years old
- Be English-speaking
- Using guselkumab, infliximab, golimumab or ustekinumab
Exclusion
- Patients who do not plan on receiving follow-up care at the Brigham and Women's Arthritis Center will be excluded.
Key Trial Info
Start Date :
April 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2026
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT06004700
Start Date
April 11 2024
End Date
October 1 2026
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115